Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization (CRO) providing clinical trial and research services for pharmaceutical, biotechnology, and medical device companies. The company supports clients throughout the product development lifecycle, offering services such as preclinical development, clinical monitoring, regulatory affairs, data management, and medical device trials.
Subscribe to see Hangzhou Tigermed Consulting Co., Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Hangzhou Tigermed Consulting Co., Ltd. is a biotechnology/pharmaceutical services company headquartered in China. Xcout tracks 8 named people at Hangzhou Tigermed Consulting Co., Ltd., including Hao Wu (Co-President).
2 more named people on record for Hangzhou Tigermed Consulting Co., Ltd., with roles, board committees and tenure — see the full roster →
A few of Hangzhou Tigermed Consulting Co., Ltd.'s closest competitors — see the full list of competitors and alternatives →
Shanghai Medicilon Inc. is a contract research organization (CRO) that provides comprehensive drug discovery, chemistry, biology, CMC development, and preclinical research services. The company serves pharmaceutical and biotechnology innovators by offering integrated solutions spanning chemical synthesis, pharmacology, ADME/DMPK, and safety assessment to advance drug candidates toward IND filings.
Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO), providing comprehensive services across the entire pharmaceutical lifecycle, from initial drug discovery and preclinical investigation through to clinical development and commercial-scale production. The company specializes in the synthesis of novel peptide chemical entities for discovery purposes, along with the development of peptide-based chemistry, manufacturing, and control (CMC) processes, and their subsequent commercial manufacturing. A core area of its developmental focus is on glucagon-like peptide-1 (GLP-1) molecules, which it designs for both oral and/or injectable administration. Medtide leverages a suite of proprietary research and development platforms, including OmniPeptSynth, PeptiConjuX, PeptiNuclide LinkTech, GreenSynth Innovations, and Impurity Screening. Its client base spans multiple regions globally, including China, the United States, Japan, Europe, South Korea, and Australia. Established in 2020 as Taide Pharmaceutical (Zhejiang) Co., Ltd, the company rebranded to Medtide Inc. in February 2023 and maintains its headquarters in Hangzhou, China.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
ICON plc is a clinical research organization (CRO) that provides outsourced clinical, consulting, and commercial services to pharmaceutical, biotechnology, medical device, and government organizations. The company assists clients with drug development, clinical trials, laboratory services, regulatory affairs, and market access strategies.
Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Evidenze is a contract research organization (CRO) that provides full-service clinical research, digital health solutions, and pharmacovigilance services. The company serves biotech and small-to-medium pharmaceutical companies by offering study start-up, clinical operations, data management, biostatistics, and medical writing services to accelerate clinical trials and optimize study outcomes.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Hangzhou Tigermed Consulting Co., Ltd.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.